Sanofi will transition completely from the trivalent to quadrivalent Fluzone high-dose influenza vaccines in the US. The quadrivalent vaccine will be available for the 2020-2021 flu season.
FDA Approvals …read more
Sanofi will transition completely from the trivalent to quadrivalent Fluzone high-dose influenza vaccines in the US. The quadrivalent vaccine will be available for the 2020-2021 flu season.
FDA Approvals …read more